Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

McGill University

$25,000.00

High-throughput tissue mechanics testing apparatus in an incubator environment

FY 2016-17

Summary
Drug development starts with molecular and cell culture level research for high-throughput testing of thousandsof compounds, followed by animal testing of a selected few. By far the greatest expense however is insubsequent human trials of selected compounds. To reduce the number of compounds that reach the humantrial phase without resulting in effective medication, we will help Ontario based Aurora Scientific in thedevelopment of a new research tool. Together we propose to develop a system that will test mechanical andcontractile functionality of human or animal muscle tissues while exposed to drugs, biological mediators and/orenvironmental factors at relatively high-throughput level over a prolonged period. Targeted at contractiletissues, this tool could be of great value for many diseases such as asthma, cardiovascular diseases and muscledystrophy that are related to muscle dysfunction but lack sufficiently effective medication. With human livetissues now available from rejected donor organs, this system would be invaluable in facilitating the translationof cell and animal level studies to human tissue level.Current systems measure only single muscle tissues at great expense and effort and none of these systems allowfor in-place incubation of the tissue with drugs or inflammatory mediators. Our proposed system places highthroughput muscle tissue measurement equipment (4-8 strips) inside a custom-built incubator. We greatlyreduce the cost of this otherwise 200k+ dollar system by time-sharing the use of the control equipment betweenthe tissue measurement units. We will also design glass-bottomed baths to allow the tissues to be imaged on afluorescence microscope, allowing the tracking of certain cellular processes in real time. The whole system willbe fully automated, to allow for high throughput, highly repeatable testing over multiple days. The proposedNSERC Engage grant covers the development of a functioning prototype in a collaboration between Ontariobased Aurora Scientific Inc. and McGill University.
Program
Engage Grants Program
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
500484-2016
Name nom
Lauzon, AnneMarie
Department département
Medicine
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1552
Committee name en
Quebec Internal Decision Committee
Committee name fr
Comité de décision interne pour le Québec
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
5504
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Animal physiology and metabolism
Research subject fr
Physiologie et métabolisme des animaux
Partie
1
Nb partie
1
Application title
High-throughput tissue mechanics testing apparatus in an incubator environment
Keyword
NSERC
Application summary
Drug development starts with molecular and cell culture level research for high-throughput testing of thousandsof compounds, followed by animal testing of a selected few. By far the greatest expense however is insubsequent human trials of selected compounds. To reduce the number of compounds that reach the humantrial phase without resulting in effective medication, we will help Ontario based Aurora Scientific in thedevelopment of a new research tool. Together we propose to develop a system that will test mechanical andcontractile functionality of human or animal muscle tissues while exposed to drugs, biological mediators and/orenvironmental factors at relatively high-throughput level over a prolonged period. Targeted at contractiletissues, this tool could be of great value for many diseases such as asthma, cardiovascular diseases and muscledystrophy that are related to muscle dysfunction but lack sufficiently effective medication. With human livetissues now available from rejected donor organs, this system would be invaluable in facilitating the translationof cell and animal level studies to human tissue level.Current systems measure only single muscle tissues at great expense and effort and none of these systems allowfor in-place incubation of the tissue with drugs or inflammatory mediators. Our proposed system places highthroughput muscle tissue measurement equipment (4-8 strips) inside a custom-built incubator. We greatlyreduce the cost of this otherwise 200k+ dollar system by time-sharing the use of the control equipment betweenthe tissue measurement units. We will also design glass-bottomed baths to allow the tissues to be imaged on afluorescence microscope, allowing the tracking of certain cellular processes in real time. The whole system willbe fully automated, to allow for high throughput, highly repeatable testing over multiple days. The proposedNSERC Engage grant covers the development of a functioning prototype in a collaboration between Ontariobased Aurora Scientific Inc. and McGill University.